Attention Investors: Important Deadline for Securities Fraud Lawsuit Against Enovix Corporation Announced by Kessler Topaz Meltzer & Check LLP – Act Now!

Enovix Corporation Securities Class Action Lawsuit Investor Notification: The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Enovix Corporation (“Enovix”) (NASDAQ: ENVX) f/k/a Rodgers Silicon Valley. Lead Plaintiff Deadline: The…

Read More

Unlocking the Potential: Morgan Stanley’s Take on the Fed’s Pause and the Waiting Game for Unused Funds

The Positive Outlook of Morgan Stanley CEO James Gorman on Future Market Trends Insightful Words from the Earnings Call ICYMI – Morgan Stanley CEO James Gorman spoke on an earnings call Tuesday. Gorman expressed his confidence in the future of deal activity and underwriting as he anticipates a pause from the Federal Reserve. “I’m highly…

Read More

Join the Fun at the B. Riley Securities 3rd Annual Oncology Conference with Theriva Biologics!

Theriva Biologics to Participate in the B. Riley Securities 3rd Annual Oncology Conference Raising Awareness and Making Connections Theriva Biologics, a company focused on developing innovative therapeutics for cancer and related diseases, is gearing up to participate in the B. Riley Securities 3rd Annual Oncology Conference. This conference provides a valuable platform for the company’s…

Read More

Attention Investors: Investigate the Class Action Investigation Against PLDT Inc. with the Help of Rosen, a Leading Global Law Firm!

Welcome to the Rosen Law Firm Investigation Blog! A Closer Look at the PLDT Inc. Securities Claims Investigation Jan. 17, 2023 (GLOBE NEWSWIRE) Hey there, fellow investor! Today, we are diving into the ongoing investigation by the Rosen Law Firm regarding potential securities claims involving PLDT Inc. If you are a shareholder of PLDT Inc….

Read More

Unlocking Success: AXIM Biotechnologies Takes Major Step Towards Fentanyl Safety with Patent Filing and DEA License Application

Diagnostic Healthcare Solutions Company Developing New Test Designed to Measure Neutralizing Antibodies of Deadly Opioid Fentanyl SAN DIEGO, CA, Jan. 17, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare diagnostic solutions development company, announced today that it has filed a provisional patent…

Read More

Gen Z Embraces Rent-to-Own: Insights from Javelin Strategy Research’s Latest Report

Rent-to-Buy Option Would Put Young People on the Fast Track to Home Ownership and Banks/Fintechs on the Road to Recovery Charmingly eccentric, full of personality, and designed for maximum reader engagement SAN FRANCISCO, Jan. 17, 2023 (GLOBE NEWSWIRE) — Javelin Strategy & Research’s recent report, Mortgage Pandemic or Just the Sniffles: Fast-Track Cures and Long-Haul…

Read More